Mukherjee S, Kar M, Dutta S
Department of Medicine, Medical College, Calcutta.
J Indian Med Assoc. 1991 Nov;89(11):307-8.
Serum prolactin assays in patients of hepatic cirrhosis were analysed. Patients with cirrhosis had higher values of serum prolactin (27.2 +/- 5.1 ng/ml in males and 38.4 +/- 4.1 ng/ml in females) as compared to control subjects (p less than 0.05). Majority of patients of cirrhosis with suspected portal-systemic encephalopathy had significantly higher serum prolactin than those without encephalopathy (p less than 0.05). Significantly higher values of serum prolactin on admission had positive correlation with mortality (p less than 0.01). Clinico-biochemical severity of hepatic dysfunction was directly correlated with level of serum prolactin. The present study reveals the possibility of diagnostic and prognostic values of serum prolactin in cirrhosis, specially in clinical/sub-clinical subsets of portal-systemic encephalopathy.
对肝硬化患者的血清催乳素检测进行了分析。与对照组相比,肝硬化患者的血清催乳素值更高(男性为27.2±5.1 ng/ml,女性为38.4±4.1 ng/ml)(p<0.05)。大多数疑似门体性脑病的肝硬化患者血清催乳素显著高于无脑病患者(p<0.05)。入院时血清催乳素值显著升高与死亡率呈正相关(p<0.01)。肝功能障碍的临床生化严重程度与血清催乳素水平直接相关。本研究揭示了血清催乳素在肝硬化中,特别是在门体性脑病的临床/亚临床亚组中的诊断和预后价值的可能性。